146 related articles for article (PubMed ID: 8927039)
1. Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studies.
Poucheret P; Gross R; Cadène A; Mantéguetti M; Serrano JJ; Ribes G; Cros G
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):197-204. PubMed ID: 8927039
[TBL] [Abstract][Full Text] [Related]
2. Vanadyl treatment normalizes submandibular salivary gland insulin-like immunoreactivity in streptozotocin-diabetic rats.
Deville de Périère D; Poucheret P; Egea JC; Gross R; Masiello P; Cros G; Serrano JJ; Ribes G
Horm Metab Res; 1998 Mar; 30(3):150-2. PubMed ID: 9566858
[TBL] [Abstract][Full Text] [Related]
3. Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes.
Cam MC; Li WM; McNeill JH
Metabolism; 1997 Jul; 46(7):769-78. PubMed ID: 9225830
[TBL] [Abstract][Full Text] [Related]
4. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.
Mongold JJ; Cros GH; Vian L; Tep A; Ramanadham S; Siou G; Diaz J; McNeill JH; Serrano JJ
Pharmacol Toxicol; 1990 Sep; 67(3):192-8. PubMed ID: 2255674
[TBL] [Abstract][Full Text] [Related]
5. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the preventing effects of oral vanadyl sulfate and dietary restriction on the age-related glucose intolerance in rats.
Novelli M; De Tata V; Fierabracci V; Barbera M; Rossetti R; Masiello P
Aging Clin Exp Res; 2005 Oct; 17(5):351-7. PubMed ID: 16392408
[TBL] [Abstract][Full Text] [Related]
7. Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets.
Missaoui S; Ben Rhouma K; Yacoubi MT; Sakly M; Tebourbi O
J Diabetes Res; 2014; 2014():540242. PubMed ID: 25215302
[TBL] [Abstract][Full Text] [Related]
8. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Cam MC; Rodrigues B; McNeill JH
Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
[TBL] [Abstract][Full Text] [Related]
9. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
11. Vanadyl sulphate differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo or in vitro exposure.
Cadène A; Gross R; Poucheret P; Mongold JJ; Masiello P; Roye M; Ribes G; Serrano JJ; Cros G
Eur J Pharmacol; 1996 Dec; 318(1):145-51. PubMed ID: 9007526
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity of vanadyl sulfate in nondiabetic and streptozotocin-induced diabetic rats.
Samira M; Mounira T; Kamel K; Yacoubi MT; Ben Rhouma K; Sakly M; Tebourbi O
Can J Physiol Pharmacol; 2018 Nov; 96(11):1076-1083. PubMed ID: 30075092
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
14. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
15. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Goc A; Turyna B; Kordowiak AM
Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Assessment of Proliferative Effects of Oral Vanadium on Pancreatic Islet Volumes and Beta Cell Numbers of Diabetic Rats.
Pirmoradi L; Noorafshan A; Safaee A; Dehghani GA
Iran Biomed J; 2016; 20(1):18-25. PubMed ID: 26459400
[TBL] [Abstract][Full Text] [Related]
17. Long-term antidiabetic activity of vanadyl after treatment withdrawal: restoration of insulin secretion?
Cros GH; Cam MC; Serrano JJ; Ribes G; McNeill JH
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):191-5. PubMed ID: 8927038
[TBL] [Abstract][Full Text] [Related]
18. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
19. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
Domingo JL; Gómez M
Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
[TBL] [Abstract][Full Text] [Related]
20. Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment.
Ramanadham S; Brownsey RW; Cros GH; Mongold JJ; McNeill JH
Metabolism; 1989 Oct; 38(10):1022-8. PubMed ID: 2677609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
